Impact of an Optimized Communication on the Readmission for Adverse Drug Event

NCT03725046 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
346
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Montpellier